PubRank

S B Hulley

Author PubWeight™ 171.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988 15.40
2 Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1986 7.35
3 Carcinogenicity of lipid-lowering drugs. JAMA 1996 7.04
4 Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure. Am J Public Health 1977 5.10
5 Health policy on blood cholesterol. Time to change directions. Circulation 1992 4.71
6 HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 1977 4.47
7 The Stanford Five-City Project: design and methods. Am J Epidemiol 1985 4.06
8 Cholesterol screening in asymptomatic adults, revisited. Part 2. Ann Intern Med 1996 3.30
9 Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials 1991 3.30
10 Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med 1980 2.96
11 Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet 1977 2.66
12 Comparison of biochemical and questionnaire estimates of tobacco exposure. Prev Med 1979 2.65
13 Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J 1986 2.55
14 Preventing the heterosexual spread of AIDS. Are we giving our patients the best advice? JAMA 1988 2.54
15 The case against childhood cholesterol screening. JAMA 1990 2.51
16 Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA 1992 2.42
17 Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation 2001 2.12
18 Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA 1993 2.06
19 Cost and health implications of cholesterol lowering. Circulation 1992 2.00
20 Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA 1987 1.86
21 HIV infection and risk behaviors among heterosexuals in alcohol treatment programs. JAMA 1994 1.79
22 Cholesterol in the elderly. Is it important? JAMA 1994 1.78
23 The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease. Am J Epidemiol 1985 1.74
24 Prevalence and correlates of herpes simplex infections. The population-based AIDS in Multiethnic Neighborhoods Study. JAMA 1992 1.71
25 The impact of diuretic therapy on reported sexual function. Arch Intern Med 1991 1.61
26 Voluntary screening for human immunodeficiency virus (HIV) infection. Weighing the benefits and harms. Ann Intern Med 1989 1.56
27 Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial. Heart 2009 1.54
28 Seven-year trends in plasma low-density-lipoprotein-cholesterol in young adults: the CARDIA Study. Ann Epidemiol 1996 1.53
29 Effect of prolonged bed rest on bone mineral. Metabolism 1970 1.47
30 Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. Am J Epidemiol 1987 1.43
31 Blood pressure in young blacks and whites: relevance of obesity and lifestyle factors in determining differences. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Circulation 1996 1.40
32 Delayed effects of the military draft on mortality. A randomized natural experiment. N Engl J Med 1986 1.39
33 Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 1995 1.35
34 Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. J Chronic Dis 1977 1.31
35 Effects of the multiple risk factor intervention trial smoking cessation program on pulmonary function. A randomized controlled trial. West J Med 1992 1.26
36 Time trends in the use of cholesterol-lowering agents in older adults: the Cardiovascular Health Study. Arch Intern Med 1998 1.24
37 The status of hypertriglyceridemia as a risk factor for coronary heart disease. Clin Lab Med 1989 1.24
38 Television viewing and cardiovascular risk factors in young adults: the CARDIA study. Ann Epidemiol 1996 1.23
39 Postural hypotension and postural dizziness in elderly women. The study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. Arch Intern Med 1992 1.23
40 Changes in HIV-related behaviors among heterosexual alcoholics following addiction treatment. Drug Alcohol Depend 1997 1.21
41 Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. JAMA 2000 1.21
42 Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone. Am J Cardiol 1985 1.19
43 Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics. Control Clin Trials 1998 1.17
44 Asymptomatic hypertriglyceridaemia. BMJ 1992 1.14
45 Effect of risk status on treatment criteria. Implications of hypertension trials. Hypertension 1989 1.10
46 Caution over journal supplements. BMJ 1993 1.09
47 Community surveillance of cardiovascular diseases in the Stanford Five-City Project. Methods and initial experience. Am J Epidemiol 1986 1.09
48 Are bisexually identified men in San Francisco a common vector for spreading HIV infection to women? Am J Public Health 1994 1.09
49 Physicians and acquired immunodeficiency syndrome. What patients think about human immunodeficiency virus in medical practice. JAMA 1989 1.07
50 Ten-year trends in cigarette smoking among young adults, 1986-1996: the CARDIA study. Coronary Artery Risk Development In Young Adults. Ann Epidemiol 1998 1.04
51 Recovery of function after hip fracture. The role of social supports. J Am Geriatr Soc 1988 1.04
52 Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures. Arch Intern Med 1997 1.04
53 Distribution of lipoproteins and apolipoproteins in young adults The CARDIA Study. Arteriosclerosis 1989 1.02
54 Plasma high-density lipoprotein cholesterol level. Influence of risk factor intervention. JAMA 1977 1.01
55 Effect of the diphosphonate EHDP on bone mineral metabolism during prolonged bed rest. J Clin Endocrinol Metab 1975 1.00
56 Levels of HIV testing and low validity of self-reported test results among alcoholics and drug users. AIDS 1994 0.98
57 Epidemiology as a guide to clinical decisions--II. Diet and coronary heart disease. West J Med 1981 0.97
58 The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest. J Clin Invest 1971 0.96
59 Serial lipid and lipoprotein responses to the American Heart Association fat-controlled diet. Am J Med 1971 0.95
60 High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med 1990 0.95
61 Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol 1993 0.95
62 Alcohol and high-density lipoprotein cholesterol: causal inference from diverse study designs. Circulation 1981 0.94
63 Mild hypertension-where shall treatment begin? West J Med 1984 0.94
64 Genetics of plasma cholesterol and triglycerides: a study of adult male twins. Acta Genet Med Gemellol (Roma) 1976 0.93
65 The cost of hospitalization for firearm injuries. JAMA 1988 0.93
66 Risk factor modification after myocardial infarction. Ann Intern Med 1988 0.92
67 Effect of health education on dietary behavior: the Stanford Three Community Study. Am J Clin Nutr 1981 0.92
68 Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials. Prev Med 1985 0.90
69 Does dietary health education reach only the privileged? The Stanford Three Community Study. Circulation 1982 0.89
70 Joint effects of serum triglycerides and LDL and HDL cholesterol. Circulation 1993 0.89
71 Childhood cholesterol screening: contraindicated. JAMA 1992 0.88
72 The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipids. Prev Med 1981 0.88
73 Role of nutritional status and weight loss in HIV seroconversion among Rwandan women. J Acquir Immune Defic Syndr 1993 0.88
74 Predictors of cardiovascular events and mortality in the Systolic Hypertension in the Elderly Program pilot project. Am J Epidemiol 1987 0.87
75 Correlates of high density lipoprotein cholesterol in women studied by the method of co-twin control. Am J Epidemiol 1989 0.87
76 Hormones to prevent coronary disease in women: when are observational studies adequate evidence? Ann Intern Med 2000 0.87
77 Quality control of biochemical data in the Multiple Risk Factor Intervention Trial: Central Laboratory. Control Clin Trials 1986 0.87
78 Problems with the report of the Expert Panel on blood cholesterol levels in children and adolescents. Arch Pediatr Adolesc Med 1995 0.86
79 HIV antibody testing in young, urban adults. Arch Intern Med 1992 0.85
80 Lipid and lipoprotein responses of hypertriglyceridaemic outpatients to a low-carbohydrate modification of the A.H.A. fat-controlled diet. Lancet 1972 0.85
81 Symposium on CHD prevention trials: design issues in testing life style intervention. Am J Epidemiol 1978 0.84
82 The plasma lipoproteins as risk factors: comparison of electrophoretic and ultracentrifugation results. Metabolism 1982 0.84
83 Phosphate supplementation as an adjunct in the therapy of multiple myeloma. Arch Intern Med 1968 0.83
84 Venous thromboembolic events associated with hormone replacement therapy. JAMA 1997 0.83
85 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 2. Clinical epidemiology: the conceptual basis for interpreting risk factors. J Am Coll Cardiol 1996 0.82
86 Sexually transmitted diseases among young heterosexual urban adults. Public Health Rep 1994 0.81
87 Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis. Circulation 1986 0.81
88 Health policy for treating hyperlipidemia: analogy with hypertension and prospects for the next decade. Am J Cardiol 1986 0.81
89 Relationship between carotenoids and cancer. The Multiple Risk Factor Intervention Trial (MRFIT) Study. Cancer 1989 0.80
90 Attempts to prevent disuse osteoporosis by treatment with calcitonin, longitudinal compression and supplementary calcium and phosphate. J Clin Endocrinol Metab 1973 0.80
91 Plasma cholesterol. Can it be too low? Arch Intern Med 1981 0.80
92 Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardiol 1990 0.80
93 Postmenopausal hormones and heart disease. J Am Coll Cardiol 2001 0.79
94 Choice and use of blood lipid tests. An epidemiologic perspective. Arch Intern Med 1983 0.79
95 Quantitation of serum lipoproteins by electrophoresis on agarose gel: standardization in lipoprotein concentration units (mg-100 ml) by comparison with analytical ultracentrifugation. J Lipid Res 1971 0.79
96 Hormone treatment--misconceptions and agreements. Eur Heart J 2002 0.77
97 Systolic hypertension in the elderly program (SHEP). The first three months. J Am Geriatr Soc 1986 0.77
98 Calcium intake and blood pressure in elderly women. Am J Epidemiol 1992 0.76
99 Effect of potassium depletion in normal males: an Apollo 15 simulation. Aviat Space Environ Med 1975 0.76
100 Serum cholesterol, blood pressure, and mortality. Lancet 1987 0.76
101 Systolic Hypertension in the Elderly Program, Pilot Study (SHEP-PS): morbidity and mortality experience. J Hypertens Suppl 1986 0.76
102 Circadian variation in ventricular arrhythmias in hypertensive men. Am J Cardiol 1992 0.76
103 Student views on nuclear war. Am J Public Health 1986 0.75
104 Toward a more balanced cholesterol policy. Circulation 1994 0.75
105 Screening for high serum cholesterol concentrations in children. J Pediatr 1992 0.75
106 Changes in sexual behavior by young urban heterosexual adults in response to the AIDS epidemic. Public Health Rep 1993 0.75
107 Blood-pressure-lowering treatment. Lancet 2001 0.75
108 Cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1992 0.75
109 Long-term mortality after primary prevention for cardiovascular disease. JAMA 1992 0.75
110 Screening for high cholesterol. J Gen Intern Med 1990 0.75
111 Does eating garlic lower cholesterol? Ann Intern Med 1994 0.75
112 Children should not be routinely screened for high blood cholesterol. Am J Dis Child 1990 0.75
113 Calcium intake and hypertension. J Nutr 1995 0.75
114 Reducing dietary intake of fat and cholesterol in children. JAMA 1995 0.75
115 Silent myocardial ischemia in men with systemic hypertension and without clinical evidence of coronary artery disease. Am J Cardiol 1992 0.75
116 Disease risk and the health of the public. Mobius 1984 0.75
117 A novel use of the link-file system for longitudinal studies of HIV infection: a practical solution to an ethical dilemma. AIDS 1993 0.75
118 The dilemma of mild hypertension. JAMA 1984 0.75
119 The high density lipoproteins. Adv Exp Med Biol 1978 0.75
120 Designing behavioural and social science to impact practice and policy in HIV prevention and care. The Executive Committee of the Center for AIDS Prevention Studies (CAPS). Int J STD AIDS 1996 0.75
121 Diet-heart policy: tailoring to individual needs. Prog Clin Biol Res 1981 0.75
122 Characteristics of smoking- discordant monozygotic twins. Prog Clin Biol Res 1981 0.75
123 Effect of renal arterial and systemic infusion of phosphate on urinary Ca excretion. Am J Physiol 1969 0.75
124 Abnormal urinary sediment during therapy with synthetic salmon calcitonin. J Clin Endocrinol Metab 1971 0.75
125 AHA Conference Report on Cholesterol. Diagnosis, evaluation, and treatment: current status and issues. Circulation 1989 0.75
126 Why teachers with AIDS belong in the classroom. JAMA 1988 0.75
127 Beneficial effects from systematic dosage reduction of the diuretic, chlorthalidone: a randomized study within a clinical trial. Am Heart J 1985 0.75
128 Treatment for "mild" hypertension. N Engl J Med 1983 0.75
129 Environmental determinants, liver function, and high density lipoprotein cholesterol levels. Am J Epidemiol 1983 0.75
130 The effect of bedrest on adrenal function. Space Life Sci 1974 0.75
131 Deaths from injury, violence, and suicide in secondary prevention trials of cholesterol lowering. N Engl J Med 1991 0.75
132 Quality control in the MRFIT local screening and clinic laboratory. Control Clin Trials 1986 0.75
133 The epidemiology of AIDS, fall 1987. J Am Podiatr Med Assoc 1988 0.75